Ultra-Low Dose of Superparamagnetic Iron Oxide Nanoparticles for Sentinel Lymph Node Detection in Patients with Breast Cancer.
Nushin MirzaeiFredrik WärnbergPontus ZaarHenrik LeonhardtRoger Olofsson BaggePublished in: Annals of surgical oncology (2023)
SLN detection using 0.1 mL ultra-low dose SPIO injected intradermally was successful in all patients. A future analysis will determine whether the approach using an ultra-low dose of SPIO injected intradermally will minimize skin staining and MRI artefacts.
Keyphrases
- flow cytometry
- low dose
- sentinel lymph node
- iron oxide nanoparticles
- high dose
- high resolution
- end stage renal disease
- ejection fraction
- early stage
- chronic kidney disease
- newly diagnosed
- lymph node
- neoadjuvant chemotherapy
- magnetic resonance imaging
- real time pcr
- prognostic factors
- peritoneal dialysis
- label free
- rectal cancer
- patient reported
- radiation therapy
- mass spectrometry
- locally advanced